USPTO serial 79415723
AVC-BOOSTER
Reviewed by CopyMark Law Group
- Filing date
- Status date
- Registration date
- —
- Examiner
- SEVERSON, JUSTIN
- Law office
- TMO LAW OFFICE 111
What this means
These status codes mean the trademark application is abandoned and no longer pending. Common reasons include missing an Office Action response (600), filing without a valid basis (602), express abandonment by the applicant (604), or failure to respond to an examiner's inquiry (618). Revival may be possible in limited circumstances. If abandonment was unintentional, consult counsel about a petition to revive. Otherwise file a new application if protection is still needed.
Need help with AVC-BOOSTER?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Owner
Goods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 001 | Chemical products for use in industry, science, and photography, namely, monoclonal antibodies and recombinant proteins used in scientific in-silico, invitro, in-vivo, and/or clinical research and development relating to immunooncology | ACTIVE | — |
| 005 | Pharmaceutical substances and preparations for human use, namely for treatment for cancer, inflammatory diseases, auto immune diseases and/or infectious diseases; biopharmaceutical substances and preparations for human use, namely for treatment for cancer, inflammatory diseases, auto immune diseases and/or infectious diseases | ACTIVE | — |
| 041 | Educational services, namely, arranging and conducting conferences, seminars, workshops and classes in the fields of chemistry, medicinal chemistry, biochemistry, biotechnology, drug research, and/or drug and pharmaceutical development; training services, namely, providing training in the fields of chemistry, medicinal chemistry, biochemistry, biotechnology, drug research, and/or drug and pharmaceutical development | ACTIVE | — |
| 042 | Medical and scientific research services; industrial research services in the field of treatment of cancer, inflammatory diseases, auto immune diseases and/or infectious diseases; pharmaceutical and biopharmaceutical research and development services; development, research, laboratory analysis and testing of pharmaceutical and biopharmaceutical drugs and for semi-finished chemicals and chemical products for use in pharmaceuticals; development of test systems in the nature of cell culture models, animal models and companion diagnostics for pharmaceutical and biopharmaceutical products; chemical analysis; computer system analysis and programming, namely, the development of prototypes and collection and processing of medical data for scientific research, development of databases in the medical, pharmaceutical and biopharmaceutical fields | ACTIVE | — |
| 044 | Medical services; medical and pharmaceutical advisory and consultancy services; medical care services. | ACTIVE | — |
| 045 | Legal services relating to the exploitation of patents; management and licensing of patents; licensing of intellectual property. | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by Avidicure IP B.V.
- Other trademarks in Class 001
- Other trademarks in Class 005
- Other trademarks in Class 041
- Other trademarks in Class 042
- Other trademarks in Class 044
- Other trademarks in Class 045
- Similar marks named AVC-BOOSTER
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Jul 16, 2026 | OPNX | NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB | — |
| Jun 29, 2026 | OPNS | NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB | — |
| Jun 29, 2026 | OPNR | NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB | — |
| Feb 17, 2026 | MAB2 | ABANDONMENT NOTICE MAILED - FAILURE TO RESPOND | The trademark application was abandoned because a required response or document was not filed by the deadline — usually a missed Office Action response. The application is dead unless a petition to revive is granted within a limited time. |
| Feb 17, 2026 | ABN2 | ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE | The trademark application was abandoned because a required response or document was not filed by the deadline — usually a missed Office Action response. The application is dead unless a petition to revive is granted within a limited time. |
| Sep 5, 2025 | NREP | NEW REPRESENTATIVE AT IB RECEIVED | — |
| Aug 23, 2025 | RFNT | REFUSAL PROCESSED BY IB | — |
| Aug 2, 2025 | RFCS | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB | — |
| Aug 2, 2025 | RFRR | REFUSAL PROCESSED BY MPU | — |
| Jun 12, 2025 | RFCR | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW | — |
| Jun 11, 2025 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Jun 3, 2025 | DOCK | ASSIGNED TO EXAMINER | — |
| Feb 14, 2025 | MAFR | APPLICATION FILING RECEIPT MAILED | — |
| Feb 14, 2025 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Feb 14, 2025 | LIMI | LIMITATION FROM ORIGINAL APPLICATION ENTERED | — |
| Jan 30, 2025 | REPR | SN ASSIGNED FOR SECT 66A APPL FROM IB | — |